NASDAQ: LTGO · Health Care / Biotechnology: Pharmaceutical Preparations

Latigo Biotherapeutics Inc.

How Latigo Biotherapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.0B

Price

$15.54

P/E

-0.2

EPS (TTM)

$-96.68

Dividend yield

0.0%

52-week range

$14.00–$16.70

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources